Literature DB >> 21154912

Cholecystokinin: a multi-functional molecular switch of neuronal circuits.

Soo Yeun Lee1, Ivan Soltesz.   

Abstract

Cholecystokinin (CCK), a peptide originally discovered in the gastrointestinal tract, is one of the most abundant and widely distributed neuropeptides in the brain. In spite of its abundance, recent data indicate that CCK modulates intrinsic neuronal excitability and synaptic transmission in a surprisingly cell-type specific manner, acting as a key molecular switch to regulate the functional output of neuronal circuits. The central importance of CCK in neuronal networks is also reflected in its involvement in a variety of neuropsychiatric and neurological disorders including panic attacks and epilepsy.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21154912      PMCID: PMC3005241          DOI: 10.1002/dneu.20815

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  76 in total

Review 1.  Novel approaches to targeting neuropeptide systems.

Authors:  B P Roques
Journal:  Trends Pharmacol Sci       Date:  2000-12       Impact factor: 14.819

2.  Cell type-specific gating of perisomatic inhibition by cholecystokinin.

Authors:  Csaba Földy; Soo Yeun Lee; János Szabadics; Axel Neu; Ivan Soltesz
Journal:  Nat Neurosci       Date:  2007-08-05       Impact factor: 24.884

3.  Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations.

Authors:  Thomas Klausberger; Laszlo F Marton; Joseph O'Neill; Jojanneke H J Huck; Yannis Dalezios; Pablo Fuentealba; Wai Yee Suen; Edit Papp; Takeshi Kaneko; Masahiko Watanabe; Jozsef Csicsvari; Peter Somogyi
Journal:  J Neurosci       Date:  2005-10-19       Impact factor: 6.167

4.  Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.

Authors:  C Rose; F Vargas; P Facchinetti; P Bourgeat; R B Bambal; P B Bishop; S M Chan; A N Moore; C R Ganellin; J C Schwartz
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

5.  Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices.

Authors:  M Migaud; B P Roques; C Durieux
Journal:  Neuropharmacology       Date:  1994-06       Impact factor: 5.250

6.  Peptidergic modulation of intrathalamic circuit activity in vitro: actions of cholecystokinin.

Authors:  C L Cox; J R Huguenard; D A Prince
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

7.  Cholecystokinins in rat cerebral cortex: identification, purification and characterization by immunochemical methods.

Authors:  G J Dockray
Journal:  Brain Res       Date:  1980-04-21       Impact factor: 3.252

8.  Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others.

Authors:  Miranda A Karson; Kevin C Whittington; Bradley E Alger
Journal:  Neuropharmacology       Date:  2007-07-01       Impact factor: 5.250

9.  Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus.

Authors:  Miranda A Karson; Ai-Hui Tang; Teresa A Milner; Bradley E Alger
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

Review 10.  Cholecystokinin receptors.

Authors:  S A Wank
Journal:  Am J Physiol       Date:  1995-11
View more
  35 in total

1.  Synapsin II Regulation of GABAergic Synaptic Transmission Is Dependent on Interneuron Subtype.

Authors:  Pedro Feliciano; Heidi Matos; Rodrigo Andrade; Maria Bykhovskaia
Journal:  J Neurosci       Date:  2017-01-13       Impact factor: 6.167

Review 2.  Olfaction under metabolic influences.

Authors:  Brigitte Palouzier-Paulignan; Marie-Christine Lacroix; Pascaline Aimé; Christine Baly; Monique Caillol; Patrice Congar; A Karyn Julliard; Kristal Tucker; Debra Ann Fadool
Journal:  Chem Senses       Date:  2012-07-25       Impact factor: 3.160

Review 3.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

4.  Cholecystokinin selectively activates short axon cells to enhance inhibition of olfactory bulb output neurons.

Authors:  Xiang Liu; Shaolin Liu
Journal:  J Physiol       Date:  2018-04-16       Impact factor: 5.182

Review 5.  New dimensions of interneuronal specialization unmasked by principal cell heterogeneity.

Authors:  Esther Krook-Magnuson; Csaba Varga; Sang-Hun Lee; Ivan Soltesz
Journal:  Trends Neurosci       Date:  2011-11-24       Impact factor: 13.837

6.  Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells.

Authors:  Sang-Hun Lee; Ivan Soltesz
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

7.  Increased cholecystokinin labeling in the hippocampus of a mouse model of epilepsy maps to spines and glutamatergic terminals.

Authors:  M S Wyeth; N Zhang; C R Houser
Journal:  Neuroscience       Date:  2011-12-03       Impact factor: 3.590

Review 8.  Basket cell dichotomy in microcircuit function.

Authors:  Caren Armstrong; Ivan Soltesz
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

9.  Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery.

Authors:  Nasir Mirza; Olga Vasieva; Anthony Guy Marson; Munir Pirmohamed
Journal:  Hum Mol Genet       Date:  2011-08-18       Impact factor: 6.150

10.  Neto Auxiliary Subunits Regulate Interneuron Somatodendritic and Presynaptic Kainate Receptors to Control Network Inhibition.

Authors:  Megan S Wyeth; Kenneth A Pelkey; Xiaoqing Yuan; Geoffrey Vargish; April D Johnston; Steven Hunt; Calvin Fang; Daniel Abebe; Vivek Mahadevan; André Fisahn; Michael W Salter; Roderick R McInnes; Ramesh Chittajallu; Chris J McBain
Journal:  Cell Rep       Date:  2017-08-29       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.